Cetuximab has received approval from the Drug Controller General of India (DCGI) for its effectiveness in treating head and neck cancerfrom Healthcare/Biotech-Industry-Economic Times https://ift.tt/9otIiNp
via IFTTT
Lupin launches biosimilar cetuximab in pact with Enzene
Cetuximab has received approval from the Drug Controller General of India (DCGI) for its effectiveness in treating head and neck cancerfrom Healthcare/Biotech-Industry-Economic Times https://ift.tt/9otIiNp
via IFTTT
0 comments:
Post a Comment